Uterine Transplantation, Abdominal Trachelectomy, and Other Reproductive Options for Cancer Patients

More and more women with cancer issues are now raising fertility concerns as survival improves and childbearing is delayed. Pregnancy is no longer contraindicated in cancer patients including breast and endometrial cancer survivors. In fact, survival in patients treated for breast cancer who subsequently become pregnant is actually higher than that in patients who do not become pregnant. “Therapeutic” abortions are no longer recommended. Assisted reproductive technology (ART) have been associated with ovarian neoplasms, but the association is probably not causal. Neither ART nor hormone replacement is contraindicated in cancer patients. Our institution is very supportive of patients and the difficult decisions cancer survivors face. Using a program of counseling and close collaboration between oncologists, perinatologists, and reproductive endocrinologists, informed patients are offered every possible option, including ART and uterine transplantation, to achieve their family planning objectives.

[1]  J. Hardy,et al.  Replantation of uterus and ovaries in dogs, with successful pregnancy. , 1966, Archives of surgery.

[2]  A. Rossier.  Letter to the Editor , 1986, Paraplegia.

[3]  R. Peschel,et al.  Sequelae of lateral ovarian transposition in irradiated cervical cancer patients. , 1991, International journal of radiation oncology, biology, physics.

[4]  J. Sciarra.  Reproductive health: a global perspective. , 1993, American journal of obstetrics and gynecology.

[5]  R. Theriault,et al.  Randomized prospective trial of estrogen-replacement therapy in women with a history of breast cancer. , 1994, Journal of the National Cancer Institute. Monographs.

[6]  A. Whittemore.  The risk of ovarian cancer after treatment for infertility. , 1994, The New England journal of medicine.

[7]  M. Wikland,et al.  Comparative study of transvaginal sonography and hysteroscopy for the detection of pathologic endometrial lesions in women with postmenopausal bleeding. , 1994, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[8]  S. Self,et al.  Ovarian tumors in a cohort of infertile women. , 1994, The New England journal of medicine.

[9]  R. Gittes,et al.  Transplantation of reproductive organs , 1995, Microsurgery.

[10]  E. Cicinelli,et al.  Transabdominal Sonohysterography, Transvaginal Sonography, and Hysteroscopy in the Evaluation of Submucous Myomas , 1995, Obstetrics and gynecology.

[11]  G. del Priore,et al.  Risk of ovarian cancer after treatment for infertility. , 1995, The New England journal of medicine.

[12]  W. Willett,et al.  Does induced or spontaneous abortion affect the risk of breast cancer? , 1996, Epidemiology.

[13]  D. Neuberg,et al.  A randomized trial of megestrol acetate with or without premarin in the treatment of potentially responsive metastatic breast cancer: A study of the Eastern Cooperative Oncology Group (E2185) , 1996, Cancer.

[14]  B Fisher,et al.  Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors. , 1996, Journal of the National Cancer Institute.

[15]  R. Kudo,et al.  [Gynecologic malignancies]. , 1997, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.

[16]  GIUSEPPE DEL PRIORE,et al.  Treatment of Continuous Data as Categoric Variables in Obstetrics and Gynecology , 1997, Obstetrics and gynecology.

[17]  T. Ehlen,et al.  Successful term pregnancy following conservative debulking surgery for a stage IIIA serous low-malignant-potential tumor of the ovary: a case report. , 1997, Gynecologic oncology.

[18]  H. Mouridsen,et al.  Should women be advised against pregnancy after breast-cancer treatment? , 1997, The Lancet.

[19]  Joshua R. Smith,et al.  Abdominal radical trachelectomy: a new surgical technique for the conservative management of cervical carcinoma. , 1998, British journal of obstetrics and gynaecology.

[20]  W. P. Evans,et al.  Comparison of the relative incidence of impalpable invasive breast carcinoma and ductal carcinoma in situ in cancers detected in patients older and younger than 50 years of age. , 1997, Radiology.

[21]  T. Kaku,et al.  Relationship between pelvic lymph node involvement and other disease sites in patients with ovarian cancer. , 1997, Gynecologic oncology.

[22]  Julian Peto,et al.  Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer , 1997, The Lancet.

[23]  G. Priore,et al.  Treatment of Continuous Data as Categoric Variables in Obstetrics and Gynecology , 1997, Obstetrics and gynecology.

[24]  M. Plante,et al.  Pregnancies after radical vaginal trachelectomy for early-stage cervical cancer. , 1998, American journal of obstetrics and gynecology.

[25]  Daniel S. Miller,et al.  Cancer incidence and mortality, 1973‐1995 , 1998 .

[26]  T. Bernik,et al.  Carcinoma of the breast during pregnancy: a review and update on treatment options. , 1998, Surgical oncology.

[27]  P. Romestaing,et al.  First case of pregnancy after radical trachelectomy and pelvic irradiation. , 1999, Gynecologic oncology.

[28]  J. Magrina,et al.  Contralateral pelvic and aortic lymph node metastasis in clinical stage I epithelial ovarian cancer. , 1999, Gynecologic oncology.

[29]  A. Venn,et al.  Risk of cancer after use of fertility drugs with in-vitro fertilisation , 1999, The Lancet.

[30]  D. Meirow.  Ovarian injury and modern options to preserve fertility in female cancer patients treated with high dose radio-chemotherapy for hemato-oncological neoplasias and other cancers. , 1999, Leukemia & lymphoma.

[31]  L. Garfinkel,et al.  U.S. cancer incidence, mortality and survival: 1973-1996. , 1999, Statistical bulletin.

[32]  F. Guidozzi,et al.  Estrogen replacement therapy for ovarian carcinoma survivors: a randomized controlled trial , 1999 .

[33]  M. Fernö,et al.  Hormone replacement therapy before breast cancer diagnosis significantly reduces the overall death rate compared with never-use among 984 breast cancer patients , 1999, British Journal of Cancer.

[34]  A. Patchefsky,et al.  Postmenopausal hormone replacement therapy: effect on diagnosis and outcome in early-stage invasive breast cancer treated with conservative surgery and radiation. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  G. Hortobagyi,et al.  Estrogen replacement therapy after localized breast cancer: clinical outcome of 319 women followed prospectively. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  B. Modan,et al.  The risk for cancer among children of women who underwent in vitro fertilization , 2000, Cancer.

[37]  H M Bonél,et al.  Prediction of deep myometrial invasion in patients with endometrial cancer: clinical utility of contrast-enhanced MR imaging-a meta-analysis and Bayesian analysis. , 2000, Radiology.

[38]  M. Follen,et al.  Outcome and Reproductive Function After Conservative Surgery for Borderline Ovarian Tumors , 2000, Obstetrics and gynecology.

[39]  A. Trounson,et al.  Evaluation of the long-term function of cryopreserved ovarian grafts in the mouse, implications for human applications , 2000, Molecular and Cellular Endocrinology.

[40]  G. Yang,et al.  Endometrial biopsy using the Tao Brush method. A study of 50 women in a general gynecologic practice. , 2000, The Journal of reproductive medicine.

[41]  F. Montz,et al.  Retrograde seeding of malignant cells during hysteroscopy in presumed early endometrial cancer. , 2000, Gynecologic oncology.

[42]  P. Kandela.  Uterine transplantation failure causes Saudi Arabian government clampdown. , 2000, Lancet.

[43]  G. del Priore,et al.  The accuracy of hysteroscopic visual impression for diagnosing endometrial complex atypical hyperplasia or cancer , 2000 .

[44]  G. del Priore,et al.  Endometrial brush biopsy for the diagnosis of endometrial cancer. , 2001, The Journal of reproductive medicine.